|
Volumn 102, Issue 5 B, 1997, Pages 85-89
|
Postexposure prophylaxis for human immunodeficiency virus at San Francisco General Hospital
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
DIDANOSINE;
HEPATITIS B ANTIBODY;
LAMIVUDINE;
ZIDOVUDINE;
CHEMOPROPHYLAXIS;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
GENERAL HOSPITAL;
HEALTH CARE PERSONNEL;
HEPATITIS B;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
NEEDLESTICK INJURY;
OCCUPATIONAL EXPOSURE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
UNITED STATES;
VIRUS TITRATION;
ANTI-HIV AGENTS;
COUNSELING;
HEALTH PERSONNEL;
HIV INFECTIONS;
HOSPITALS, GENERAL;
HOTLINES;
HUMANS;
OCCUPATIONAL EXPOSURE;
RISK;
RISK FACTORS;
SAN FRANCISCO;
|
EID: 0030741599
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(97)00157-5 Document Type: Conference Paper |
Times cited : (15)
|
References (7)
|